Skip to content

Assessment of MDD Management in Andalusia

Assessment of MDD Management Strategies in Andalusia: A Sub-analysis of the PismaEP Study

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01510886
Acronym
PismaEP
Enrollment
5309
Registered
2012-01-18
Start date
2012-06-30
Completion date
2013-09-30
Last updated
2014-08-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

MDD Management Strategies

Keywords

MDD, management, Andalusia, Database, PismaEP

Brief summary

The main objectives of this study are to describe medical professionals responsible of the management of patients with MDD in a representative region of Andalusia (in terms of type of sites managing the disease, and referral to SC criteria); Describe MDD patient characteristics at inclusion in the PISMA-Ep Study; and to evaluate those factors associated to a higher incidence of referral from PC to SC.

Detailed description

Assessment of MDD management strategies in Andalusia: A Sub-analysis of the PismaEP Study

Interventions

None listed

Sponsors

AstraZeneca
Lead SponsorINDUSTRY

Study design

Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* MDD Diagnosis Participants of the PismaEP study 18 yo. or older

Exclusion criteria

* No specific

Design outcomes

Primary

MeasureTime frame
Number of Visits to Primary CareFrom Jan 2010 to Jan 2011
Number of Visits to Secondary CareFrom Jan 2010 to Jan 2011
Number of ReferralsFrom Jan 2010 to Jan 2011

Secondary

MeasureTime frame
Type of diseaseFrom Jan 2010 to Jan 2011
DemographicsFrom Jan 2010 to Jan 2011
Severity of diseaseFrom Jan 2010 to Jan 2011
Type of siteFrom Jan 2010 to Jan 2011
Type of therapeutic strategyFrom Jan 2010 to Jan 2011

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026